4//SEC Filing
Goodwin Bradford S 4
Accession 0001181431-11-042506
CIK 0001385830other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 8:56 PM ET
Size
7.8 KB
Accession
0001181431-11-042506
Insider Transaction Report
Form 4
NeurogesX IncNGSX
Goodwin Bradford S
Director
Transactions
- Award
Common Stock
2011-07-26$1.65/sh+60,000$99,000→ 75,000 total - Award
Warrant
2011-07-26$0.14/sh+30,000$4,200→ 30,000 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]The securities sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from the registration requirements. NeurogesX has agreed to file a registration statement with the Commission covering the resale of the shares of common stock, including shares of common stock issuable upon exercise of the warrants, sold in the private placement.
- [F2]The purchase price per unit of shares and warrants (with one unit being comprised of one share of common stock and a warrant to purchase 0.5 shares of common stock) is $1.72, and is based on the $1.65 per share consolidated closing bid price of NGSX common stock on the NASDAQ Global Market on July 21, 2011. $1.65 of the unit price is attributable to the share of common stock, and $0.07 is attributable to the warrant to purchase 0.5 shares of common stock. Thus, the price attributable to the warrant for each whole share underlying such warrant is $0.14.
- [F3]The Warrants are immediately exercisable.
- [F4]The Expiration Date is five years from the close date.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeother
Related Parties
1- filerCIK 0001293633
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 8:56 PM ET
- Size
- 7.8 KB